Abstract:
Introduction
The dipyrone (sodium salt of the 1-phenyl-2,3-dimethyl-4-methyl aminomethane sulfonate-5-pyrazolone) is a soluble white crystalline powder that presents analgesic and antipyretic activity available in oral, rectal and injectable forms [1] . It is widely used in several countries. Its therapeutic relevance and importance of the side effects have prompted the development of several methods for its determination both in pharmaceutical preparations and biological samples. This drug can also cause occasional or rare reactions such as: transitory renal disturbances and inflammation of the renal tissue, mainly in patients with history of renal disease or in cases of overdose [2] .
The methods commonly used for dipyrone ( Fig. 1 ) determination in several pharmaceutical formulations are based on its reaction with iodide [3, 4] . For example, the Brazilian Pharmacopoeia recommends the iodometric titration of dipyrone [4] but this procedure is very slow and laborious, thus less applicable to large-scale analysis.
In order to improve performance and robustness, several methods are also reported for dipyrone determination such as spectrometric [5, 6] , electrochemical [7, 8] and chromatographic [9, 10] methods. Moreover, new trends employing flow injection procedures have been developed for the determination of dipyrone in pharmaceuticals and biological samples, with different detection systems: amperometric [11] [12] [13] , spectrophotometric [14] [15] [16] potentiometric [17] and chemiluminescent [18] [19] [20] .
Solid-phase reactor coupled in a flow injection system is an interesting strategy due to the advantages offered over the dissolved reagents, namely, the use of
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In this work, a flow-injection spectrophotometric method for dipyrone determination in pharmaceutical formulations was developed. Dipyrone sample solutions were injected into a carrier stream of deionized water and the reaction was carried out in a solid-phase reactor (12 cm, 2.0 mm i.d.) packed with Cu 3 (PO 4 ) 2(s) entrapped in a matrix of polyester resin. The Cu(II) ions were released from the solid phase reactor by the formation of Cu(II)-(dipyrone) n complex. When the complex is released, it reacts with 0.02% m/v alizarin red S in deionized water to produce a Cu(VABO 3 ) 3 complex whose absorbance was monitored at 540 nm. The calibration graph was linear over the range 5.0×10
-5 -4.0×10 -4 mol L -1 with a detection limit of 2.0×10 -5 mol L -1 and relative standard deviation for 10 successive determinations of 1.5% (2.0×10 -4 mol L -1 dipyrone solution). The calculated sample throughput was 60 h -1
. The column was stable for at least 8 h of continuous use (500 injections) at 25 o C. Pharmaceutical formulations were analyzed and the results from an official procedure measurement were compared with those from the proposed FIA method in order to validate the latter method.
reagents that are not available in soluble form, increased sensitivity, and increased injection rate. Furthermore, the use of solid-phase reactors can avoid the timeconsuming steps of reagent solution preparation and contact with the sample. The immobilization procedure is fairly expeditious, simple and non-specific [21] . The combination of flow-injection analysis with solidphase reactors has been used extensively in several pharmaceutical analyses and for a variety of purposes, including preconcentration, sample conversion, immobilized enzymes and generation of unstable reagents [22] [23] [24] [25] [26] .
The aim of this work is to propose and confirm the use of a solid-phase reactor with Cu 3 (PO 4 ) 2 for dipyrone determination (see Scheme 1). The method is based on the chelating reaction between dipyrone and immobilized copper(II) ions (step I). The released Cu(II) is complexed by alizarin red S and monitored spectrophotometrically at 540 nm (step II).
Experimental procedure

Apparatus
A twelve-channel Ismatec (Zurich, Switzerland) Model 7618-50 peristaltic pump supplied with Tygon pump tubing was used for the propulsion of the fluids. The manifold was constructed with polyethylene tubing (0.8 mm i.d.). All reference or sample solutions were injected manually into the carrier stream using an injectorcommutator [27] . Spectrophotometric measurements for the proposed method were performed with a Femto (São Paulo, Brazil) Model 435 spectrophotometer equipped with a glass flow cell (optical path 1.0 cm) connected to a Cole Parmer (Chicago, IL) model 1202-0000 twochannel strip-chart recorder. A Hewlett Packard (Boise, ID, USA) model 8452AUV-visible spectrophotometer was used in the preliminary experiments.
Reagents and chemicals
All reagents were of analytical-reagent grade and all solutions were prepared with water from a Millipore (Bedford, MA) Milli-Q system (Model UV Plus UltraLow Organics water). A 10 mmol L -1 dipyrone standard solution was prepared by dissolving the appropriate amount of dipyrone (Boheringer Ingelheim) in 50 mL of deionised water. Working standard solutions within the 5.0×10
-5 mol L -1 and 4.0×10 -4 mol L -1 dipyrone ranges were daily prepared by serial dilutions of appropriate volumes of the standard stock solution with deionised water.
The borate buffer solution (pH 9.0) was prepared by mixing appropriate volumes of 0.2 mol L -1 sodium borate (Merck) and 0.2 mol L -1 boric acid (Merck), and diluting to 500 ml with water. A 0.020% (m/v) alizarin red S solution was prepared by dissolving 200 mg of this reagent from Aldrich (Milwaukee, WI) in 1 L of borate buffer solution (pH 9.0).
The immobilization of Cu 3 (PO 4 ) 2 was made using a commercial polyester resin solution (Resapol T-208, Resana, SP, Brazil) and methyl ethyl ketone used as catalyst (Ibere, Ramires & Cia, Taboão da Serra, SP, Brazil).
Pharmaceutical dosage forms of dipyrone analysed were those commercially available in Brazil: Novalgina capsules 500 mg (Hoechst Marion Roussel Ltda.), Magnopyrol capsules 500 mg (FARMASA S.A.), Magnopyrol solution 500 mg mL -1 (FARMASA S.A.), Anador capsules 500 mg (Boheringer Ingelheim do Brasil), Anador solution 500 mg mL -1 (Boheringer Ingelheim do Brasil), Conmel solution 500 mg mL -1 (Sanofi Winthrop Farmacêutica Ltda). For analysis of capsules of 500 mg, 20 capsules of the drug were used. The material from each capsule was removed and accurately weighed, allowing the mean weight of the contents of a single capsule to be estimated. Thereafter, the material was homogenised and an appropriate amount was sampled, dissolved in deionised water and filtered. For analyses of sample solutions of 500 mg mL -1 , five samples were used and the solution contents were mixed for representative purposes. Thereafter, the required volume was sampled and diluted with deionised water.
Preparation and immobilization of Cu 3 (PO 4 ) 2
Preparation and immobilization of Cu 3 (PO 4 ) 2 was similar to that previously reported [28] : Cu 3 (PO 4 ) 2 was prepared by reacting CuCO 3 .Cu(OH) 2 (Vetec) with concentrated phosphoric acid (Merck).
Immobilization method
Ten grams of polyester resin solution were transferred to a polyethylene flask; then 10 g of Cu 3 (PO 4 ) 2 were added and after manual homogenization, 0.5 mL of the catalyst (methylethyl ketone) were added and stirred until there was an increase of viscosity. After 3-4 h, a rigid solid Flow-injection spectrophotometric determination of dipyrone in pharmaceutical formulations using a solid-phase reactor with copper(II) phosphate is obtained, which was broken with a hammer and a domestic liquefier was used to obtain small particles.
The particle size was selected by sieving on known mesh sieves. With this amount, it is possible to prepare more than 50 reactors, once its solid-phase reactor was prepared by packing ca. 350 mg of polyester particles (100±350 mm) containing the immobilized copper(II) phosphate into 13 cm long polyethylene tubes (2.0 mm i.d.) by means of suction with a syringe and fixed in the column with small pieces of glass wool.
Flow injection procedure
A schematic diagram of the flow manifold is shown in Fig. 2 . As suggested in the literature [29] , dipyrone can form a complex with Cu(II). However there are no data in the literature about the structure of this complex. The Cu(II) ions can be spectrophotometrically detected with alizarin red S through the ternary complex whose structure is 1:3 (Cu:VABO 3 ) [30] . When a solution of dipyrone is injected, Cu(II) ions are released from the solid-phase reactor due the formation of Cu(II)-dipyrone complex. Thus, when alizarin red S (pH 9.0) is mixed into the carrier solution containing Cu(II)-dipyrone complex, it replaces the aspartame ligand leading to the formation of a colored complex (Cu(II)-alizarin) of which the absorbance measured at 540 nm is proportional to the dipyrone concentration.
Results and discussion
Chemical parameters
In order to obtain either a long lifetime of the solid phase reactor or a high sensitivity of the proposed methodology, several solutions were investigated as carriers: deionized water, acetate buffer solutions 0.05 mol L The best results were obtained with deionized water as the carrier solution because, for acid solutions, Cu(II) ions were released from the solid reactor even without the adding of dipyrone solution. For basic solutions, the absorbance signal decreased significantly due the Cu(OH) 2 formation in equilibrium with the Cu 3 (PO) 4 in the reactor making it difficult for Cu(II)-dipyrone complex formation.
Pyrogallol vilolet and alizarin red S were evaluated as colorimetric reagents for determination of Cu(II). The best results were obtained with alizarin red S that was chosen for further studies. The absorption spectrum of the Cu(II)-alizarin complex shows that the maximum absorbance difference between the alizarin solution and Cu(II)-alizarin complex is found at 540 nm. This wavelength was selected for further studies.
Solid-phase reactor parameters
The performance of solid-phase reactors can be affected by several parameters. In order to obtain the best results for the proposed procedure, some factors were evaluated such as: column length, column internal diameter, Cu(II)/polyester ratio, and particle size. Before the first injection, all tested solid-phase reactors were conditioned by passing the carrier solution for 10 min for the best compaction of the particles in the column. Reproducible absorbance signals were obtained after five injections at least. The preparation of the solidphase reactors was evaluated for three different ratios of Cu 3 (PO 4 ) 2 /polyester resin: 12.5%, 25% and 50% (m/m). Reactors prepared with 50% (m/m) showed the highest sensitivity and was chosen for further studies. Two particle size ranges (100-350 and 350-500 mm) selected by sieving the triturated material were tested with the compromise of minimize difficulties in regard to the operating conditions (operation at low pressure).
The best results in terms of sensitivity and reproducibility were obtained with particle size of 100-350 mm. Solid-phase reactors with different internal diameters (1.0, 1.5 and 2.0 mm) were prepared in order to optimize that parameter. All columns were prepared with the same length (8.0 cm) and particle size (100-350 mm). Best results were performed with solid-phase reactor of 2.0 mm of internal diameter due the highest absorbance signal and easily preparation of these columns. Fig. 3 shows the influence of the column length on the absorbance signal for a studied range of 4.0 to 20 cm at a carrier flow rate of 3.0 mL min -1 . The absorbance signals increased gradually with the increase of the column length. Nevertheless, columns larger than 12.0 cm allowed the increase in the hydrodynamic pressure, reducing the effective flow rate and, consequently, the analytical frequency. Additionally, the long-time stability of the column was investigated measuring the absorbance of dipyrone solutions containing 5.0×10
-5 to 4.0×10 -4 mol L -1 . Plot calibration curves were done daily indicating a good reproducibility with a variation in the slope around 5-6% after at least 500 injections.
Flow injection parameters
To determine the optimal conditions for the flow injection system performance, parameters such as sample loop volume and carrier flow rate were initially investigated. Table 1 presents the optimization of chemical flow injection parameters studied in this work.
The effect of varying sample loop volume from 10 to 100 cm (50-500 mL) on the analytical signal was evaluated by injection of the same concentration of dipyrone passed through the column with immobilized copper phosphate. The height peak was found to increase with the sample volume between 50 and 100 mL, staying practically constant for higher volumes. This behavior can indicate that the quantity of dipyrone in 100 mL, for these conditions, to be the maximum necessary for the complex formation. Therefore, a sample volume of 100 mL was selected for showing better engagement between sensibility and analytical frequency.
Using a univariate approach optimized the carrier flow rate. The effect of the carrier flow rate from 0.5 to 3.5 mL min -1 over the analytical signal was studied and the optimal flow rate found was 1.7 mL min -1 whereas for flow rates higher than 1.7 mL min -1 , the absorbance signals decreased due the lower contact between the sample zone and the immobilized Cu 3 (PO 4 ) 2 . The effect of reagent flow rate on the sensitivity was studied using a 0.020% (m/v) alizarin red S solution in borate buffer solution with a pH 9.0 and varying the flow rate from 0.5 to 3.5 mL min -1 . With the decrease of the flow rate, the analytical signals increased gradually due the low dilution of the reagent solution. Therefore, a flow rate of 0.5 mL min -1 was selected as the best compromise between sensitivity and sample throughput. By using these flow rates, the sample throughput was 60 measurements per hour.
The influence of the length of the tubular coiled reactor was studied in the range from 50 cm to 200 cm and was observed that the absorbance decreased continuously with an increase in the reactor length. This fact can be explained by the higher effect of the sample zone dispersion in contrast with an efficient Flow-injection spectrophotometric determination of dipyrone in pharmaceutical formulations using a solid-phase reactor with copper(II) phosphate mixture between the reagent and the sample zone that could allow an efficient reaction and, consequently, the increase in the absorbance signal. Due the rapid reaction for the complex formation, the dispersion predominates and the absorbance decreases. For this, a tubular coiled reactor with 75 cm was chosen.
Effect of the alizarin red S concentration
The concentration of alizarin red S solution was evaluated in the range of 0.005 to a maximum concentration of 0.020% (m/v) limited by the solubility of this reagent in borate buffer solution (pH 9.0). For injections of a 1.0×10 -4 mol L -1 dipyrone solution, the best results (highest absorbance signals) were obtained for a concentration of 0.020% (m/v) that was chosen for further studies.
Interferences and recovery studies
The possible interferences on the determination of dipyrone caused by common excipients used in pharmaceutical preparations were investigated by comparison of the response produced by a standard solution containing 2.0×10 -4 mol L -1 dipyrone with that produced by a similar dipyrone solution with additions of 2.0×10 -4 mol L -1 and 2.0×10 -3 mol L -1 (sodium chloride, sodium citrate, saccharin, sucrose, lactose and caffeine) of each one of these potential interferents. There were no significant interferences for the evaluated substances with exception of sodium citrate that cause a positive interference even in a 10-fold high dipyrone concentration. This interference applies the fact that citrate anions are excellent at complexing with Cu(II) ions and releases this cation more effectively than dipyrone. Samples that contained these substances could not to be analyzed for this procedure. 
Analytical curve and sample determination
The proposed method was used for the dipyrone determination in pharmaceutical formulations. Dipyrone reference solutions and samples solutions were injected in the flow system showed in Fig. 2 . The transient signals yielded are shown in Fig. 4 and the obtained results are presented in Table 3 .
The analytical curve was linear in a range of 5.0×10 -5 to 4.0×10 -4 mol L -1 . {A = 0.003 + 502.8C} where A is the absorbance and C is the dipyrone concentration in mol L -1 . The detection limit was 2.0×10 -5 mol L -1 (three times the signal blank/slope), the relative standard deviation of 10 successive dipyrone determinations was 1.5%, and the analytical frequency was 60 determinations per hour.
No significant variations on the analytical curve slope (5% to 6%) were observed for a 6-7 h work period, indicating that the proposed method could be adopted for dipyrone determination in pharmaceutical formulations with sensitive and reproducible results.
Conclusions
The proposed method showed a simple and sensitive way for dipyrone determination using a Cu(II) phosphate reactor. Results are in agreement with those obtained by the Brazilian Pharmacopoeia procedure. In addition, no pre-treatment of the samples was required. The reproducibility and stability of the solid-phase reactor make it an attractive alternative for the determination of dipyrone in a flow system, and this method may be suitable for routine determination of dipyrone in pharmaceutical formulations. 
